Plandai Biotechnology Sets for Battle Against Neurological Diseases by using Nutraceuticals

Plandaí­ Biotechnology, Inc. (OTCQB: PLPL) transforming the world of nutraceuticals by making available extracts from live plant material that deliver the highest levels of bioavailability currently in the market. These extracts are utilized to deliver a new family of drugs to safely and cost effectively treats a plethora of different diseases and conditions.

Read more »

Cognoptix: Simple Eye-Scan Test a Powerful Tool for Diagnosing Alzheimer’s Disease

Cognoptix and its technology have the ability to overhaul commonly accepted Alzheimer’s Disease diagnostic practices, providing a tool to diagnose the disease at an early stage, thereby increasing the efficacy of current therapies.

Read more »

The Briefing Room, August 24: The Week That Was in Microcap Biotech Stocks

OneMedPlace introduces a new series, “The Briefing Room”, capturing the past week’s most important developments in microcap life sciences indexes. This week, we feature Star Scientific, Kips Bay Medical, XOMA and Stellar Pharmaceuticals.

Read more »

Alzheimer’s Drug Market Is Forecast to Experience Double-Digit Growth

Valued at almost $6bn in the seven major markets in 2011 (US, Japan, France, Germany, Italy, Spain, and the UK), the Alzheimer’s disease drug market is forecast to experience double-digit growth to 2020.

Read more »

Intellect Neurosciences Files New Patent Applications for Immunotherapy Methods in Treatment of Alzheimer’s Disease

Over the next 40 years, caring for individuals with Alzheimer’s will cost American society $20 trillion –including $15 trillion to Medicare and Medicaid.

Read more »

Anavex Life Sciences Challenges the Basic Assumptions In Treating Alzheimer’s Disease

The company’s lead drug candidate for Alzheimer’s Disease (AD), ANAVEX 2-73, has successfully completed a Phase 1 single ascending dose clinical trial.

Read more »

QR Pharma Returns to OneMedForum To Present Alzheimer’s Technology

OR Pharma previously presented at OneMedForum San Francisco and will return in June to preset their technology at OneMedForum NY 2011.

Read more »

Neurotez Developing Hormone Replacement Therapy for Alzheimer’s

Could the same hormone that regulates your appetite keep you from developing Alzheimer’s?

Read more »

China Analyst Identifies 10 Pharma Stocks with Highest Growth Potential

China Analyst, a financial information website focused on U.S.-listed Chinese stocks, recently released its list of the top 10 pharmaceutical stocks with the highest upside.

Read more »

Annual Costs of Dementia Care Exceed GDP, New Report Says

If dementia care were a company, it would be the world’s largest in terms of annual revenue, surpassing even Wal-Mart.

Read more »